Tags |
|
|
Links |
|
|
E-Articles - Drug Addiction - Drugs Don't Love You Anymore
When we think of drug addiction, we simply think of somebody who’s gotten accustomed to taking an addictive substa
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
nce and can’t stop. But what causes this addiction, what is the force behind it. For instance, what is the thing w
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
hich makes the user go back time and time again to use more and more drugs. What we want to know is, why can’t the
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
just stop?
It is now believed that what drugs do is tamper with the brains way of working. Try and imagine all o
It is now believed that what drugs do is tamper with the brains way of working. Try and imagine all o
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
f the things in life, the things we hate and the things which give us pleasure. At the most basic of levels, in li
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
e we experience 2 emotions, these 2 extremes: like, and dislike. The things we like, we constantly seek to do more
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
of, and the things we dislike we seek to avoid. Let us focus on the ‘like’ side of things.
Somebody takes drugs
Somebody takes drugs
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
because they like doing so, inevitably they take more, and more etc. Soon enough they can’t stop and find themselv
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
s constantly wanting to take more drugs. Just as somebody who has a hobby seeks to do as much of it as they can. D
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
rugs, basically, become a hobby. A part of peoples’ lives. Because of the constant need to do more, to maintain th
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
sought-after effects, it is something the user likes whilst experiencing, but when coming down, or not experienci
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ng dislikes. So rather than even consider quitting and getting out of the cycle, the first idea is to take more. I
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
t is such a cycle it is sometimes hard for the addicted to know where it ends and where it begins.
Some people ar
Some people ar
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
more prone to addictive behaviour than others. This is a medical fact. Some people have used hardcore drugs such
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
as heroin, and simply decided not to take anymore one day, all on their own without any drugs rehab, and haven’t t
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ken anymore. Sure, they’ve maybe had to go through the withdrawal, something like a very long and painful hangover
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
, and the physical and psychological cravings they’ve maybe had, but in time this diminishes. Addiction can almost
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
be like love. It is easy to fall in love, and think about nothing but, whilst it is quite something else to leave
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
‘love’ behind.
Time is a great healer. At the most absolute basic level, the only way to beat drugs is to learn t
Time is a great healer. At the most absolute basic level, the only way to beat drugs is to learn t
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
o stop loving them, and find something else to fall in love with. Eventually, you’ll never look back – but forward
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/284362/e-article-Drug-Addiction--Drugs-Dont-Love-You-Anymore.html">Drug Addiction - Drugs Don't Love You Anymore</a>
BB link (for phorums):
[url=http://www.e-article.org.ua/article/284362/e-article-Drug-Addiction--Drugs-Dont-Love-You-Anymore.html]Drug Addiction - Drugs Don't Love You Anymore[/url]
Related Articles:
Sell Those Products With Yahoo Store Designer
Making the Most of your Direct Sales Holiday Season - Meet the Needs of Stressed out Moms
The Laws of Men & Love - A Layman's Philosophical Analysis of the Law
Bookmark it:
|